ROYAL BANK OF CANADA - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 35 filers reported holding SIGILON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$9,000
-40.0%
18,203
+1.1%
0.00%
Q2 2022$15,000
-46.4%
18,001
-8.3%
0.00%
Q1 2022$28,000
-53.3%
19,634
-8.8%
0.00%
Q4 2021$60,000
+400.0%
21,537
+937.9%
0.00%
Q3 2021$12,000
+71.4%
2,075
+200.7%
0.00%
Q2 2021$7,000
-74.1%
690
-43.6%
0.00%
Q1 2021$27,0001,2240.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 10,370,369$58,592,0000.61%
HARBOURVEST PARTNERS LLC 740,740$4,185,0000.39%
Monashee Investment Management LLC 317,460$1,794,0000.33%
SOUNDMARK WEALTH MANAGEMENT, LLC 50,555$286,0000.10%
Artal Group S.A. 276,000$1,559,0000.04%
Choate Investment Advisors 66,666$377,0000.02%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$8,391,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 509,629$2,879,0000.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 229,500$1,297,0000.00%
Woodline Partners LP 34,200$193,0000.00%
View complete list of SIGILON THERAPEUTICS INC shareholders